Clinical Trial Update: First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide) [EARLY_Phase 1]

View source ↗

Summary

This is a first-in-human Phase I trial of PEP-010 as a single agent and in combination with paclitaxel or gemcitabine for metastatic solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)
• PEP-010 (PEP-010)

Snippet

Sponsor: Institut Curie | Conditions: Metastatic Solid Tumor Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING